scispace - formally typeset
Open AccessJournal ArticleDOI

Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.

TLDR
The very high cumulative incidence of thrombotic complications in critically ill patients with COVID-19 pneumonia is confirmed in this updated analysis.
About
This article is published in Thrombosis Research.The article was published on 2020-07-01 and is currently open access. It has received 1305 citations till now. The article focuses on the topics: Cumulative incidence & Intensive care.

read more

Citations
More filters
Journal ArticleDOI

Cytokine Storm.

TL;DR: From the Department of Medicine, Division of Translational Medicine and Human Genetics, Center for Cytokine Storm Treatment and Laboratory, and the Center for Cellular Immunotherapies and the Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia.
Journal ArticleDOI

Incidence of Venous Thromboembolism in Hospitalized Patients with COVID-19

TL;DR: Coronavirus disease 2019 (COVID‐19) can lead to systemic coagulation activation and thrombotic complications and should be treated with anticoagulant medication.
Journal ArticleDOI

COVID-19 and diabetes mellitus: from pathophysiology to clinical management.

TL;DR: Evidence suggests that insulin and dipeptidyl peptidase 4 inhibitors can be used safely in patients with diabetes mellitus and COVID-19; metformin and sodium–glucose cotransporter 2 inhibitors might need to be withdrawn in patients at high risk of severe disease.
Journal ArticleDOI

COVID-19 update: Covid-19-associated coagulopathy.

TL;DR: Emerging insights into the pathobiology, mechanism, diagnosis, management, foundations for research and either planned or ongoing clinical trials for Covid-19-associated coagulopathy are summarized.
References
More filters
Journal ArticleDOI

Incidence of thrombotic complications in critically ill ICU patients with COVID-19.

TL;DR: The findings reinforce the recommendation to strictly apply pharmacological thrombosis prophylaxis in all COVID-19 patients admitted to the ICU, and are strongly suggestive of increasing the prophYLaxis towards high-prophylactic doses, even in the absence of randomized evidence.
Journal ArticleDOI

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.

TL;DR: There is an urgent need to improve specific VTE diagnostic strategies and investigate the efficacy and safety of thromboprophylaxis in ambulatory COVID-19 patients.
Journal ArticleDOI

Incidence of Venous Thromboembolism in Hospitalized Patients with COVID-19

TL;DR: Coronavirus disease 2019 (COVID‐19) can lead to systemic coagulation activation and thrombotic complications and should be treated with anticoagulant medication.
Related Papers (5)
Trending Questions (1)
How critical are patients who are admitted to the ICU?

Patients admitted to the ICU with COVID-19 have a high cumulative incidence of thrombotic complications, with a 49% incidence of the composite outcome.